On IHC, FLCN‐mutated BHD tumours also show frequent cathepsin K reactivity and increased expression of SOX9, in contrast to the lack of expression of SOX9 in RO, ChRCC and LOT.53, 57. This evidence concerns the gene SOX9 and chromophobe renal cell carcinoma.